deltatrials
Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT07285135

Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease

Investigating the Effects of Dietary Glycine Supplementation in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease

Sponsor: Singapore General Hospital

Interventions Glycine Placebo
Updated 1 time since 2026 Last updated: Dec 2, 2025 Started: Dec 31, 2025 Primary completion: Jul 31, 2028 Completion: Jan 31, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Metabolic Dysfunction Associated Fatty Liver Disease, this trial is actively recruiting participants. The trial is conducted by Singapore General Hospital and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2026 – present · 6 months · monthly snapshotNot Yet Recruiting

Change History

1 version recorded
Not Yet Recruiting — NA [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Singapore General Hospital
Data source: Singapore General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.